Hsbc Holdings PLC Purchases 53,970 Shares of TransMedics Group, Inc. (NASDAQ:TMDX)

Hsbc Holdings PLC grew its position in shares of TransMedics Group, Inc. (NASDAQ:TMDX) by 161.0% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 87,498 shares of the company’s stock after buying an additional 53,970 shares during the quarter. Hsbc Holdings PLC’s holdings in TransMedics Group were worth $5,452,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also recently modified their holdings of the company. Atlas Capital Advisors Inc. bought a new position in shares of TransMedics Group during the 4th quarter worth approximately $31,000. Hager Investment Management Services LLC bought a new position in shares of TransMedics Group during the 4th quarter worth approximately $33,000. Sachetta LLC bought a new stake in shares of TransMedics Group in the 4th quarter worth approximately $40,000. AlphaQuest LLC bought a new stake in shares of TransMedics Group in the 4th quarter worth approximately $52,000. Finally, Wilmington Savings Fund Society FSB bought a new stake in shares of TransMedics Group in the 3rd quarter worth approximately $149,000. Institutional investors own 99.67% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on TMDX shares. Needham & Company LLC reaffirmed a “hold” rating on shares of TransMedics Group in a report on Wednesday, April 23rd. Canaccord Genuity Group reaffirmed a “buy” rating and issued a $104.00 price target on shares of TransMedics Group in a report on Tuesday, March 11th. Three research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat, TransMedics Group presently has a consensus rating of “Moderate Buy” and an average target price of $122.70.

TransMedics Group Stock Performance

Shares of TMDX opened at $90.19 on Tuesday. The stock’s 50-day simple moving average is $74.67 and its 200 day simple moving average is $77.10. The stock has a market capitalization of $3.05 billion, a price-to-earnings ratio of 95.95 and a beta of 2.14. The company has a debt-to-equity ratio of 2.42, a quick ratio of 7.33 and a current ratio of 8.20. TransMedics Group, Inc. has a 52-week low of $55.00 and a 52-week high of $177.37.

TransMedics Group Company Profile

TransMedics Group, Inc, a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body.